Kawaguchi N, Miyakawa H, Abe K, Kitazawa E, Kako M
Central Laboratory, Teikyo University Hospital, Kawasaki.
Rinsho Byori. 1997 Nov;45(11):1072-8.
Anti-mitochondrial antibodies(AMA) are serodiagnostic markers for primary biliary cirrhosis(PBC) but heterogenous in antigen molecules which they recognize. A disease-specific AMA for PBC is anti-M2. The conventional examination methods are indirect immunofluorescence and ELISA. However, there are some problems in specificity, because the antigen preparations used are crude. Thus, analysis with Western-blotting(W-B) is needed, because it allows the identification of a molecule which the antibody reacts with. In this report, we established the optimal conditions for detecting anti-M2 with W-B in PBC. As antigen, we used mitochondrial fractions derived from beef hearts. Because a positive band at 74 kDa became negative after absorbing sera with PDH purified from porcine hearts, this band corresponded to major antigeneity of anti-M2. Titration experiments with SDS-PAGE showed that the optimal concentration of this antigen preparation for loading is 0.04 mg/ml. We also performed titration experiments to determine the optimal dilutions for second antibodies and serum samples. The results showed that the optimal dilution for second antibodies, anti-IgG and anti-IgM, were 1:3000 and 1:1000, respectively. The optimal dilution for serum samples was shown to be 1:10(2). Moreover, the W-B technique gave a positive result even for sera from AMA-negative PBC patients which had tested negative with conventional methods, if undiluted sera were examined or if anti-IgG or anti-IgM was used as a second antibody. Thus, the W-B technique is more sensitive than conventional methods of analysis. Based on these results, we will be able to detect anti-M2 with maximum efficiency, thus improving our ability to study the relationship between anti-M2 and the pathological conditions in PBC.
抗线粒体抗体(AMA)是原发性胆汁性肝硬化(PBC)的血清学诊断标志物,但其识别的抗原分子具有异质性。PBC的疾病特异性AMA是抗M2。传统的检测方法是间接免疫荧光法和酶联免疫吸附测定法(ELISA)。然而,由于所使用的抗原制剂粗糙,在特异性方面存在一些问题。因此,需要用蛋白质印迹法(W-B)进行分析,因为它能够鉴定抗体所反应的分子。在本报告中,我们确立了用W-B检测PBC患者抗M2的最佳条件。作为抗原,我们使用了源自牛心脏的线粒体组分。由于用从猪心脏纯化的丙酮酸脱氢酶吸收血清后,74 kDa处的阳性条带变为阴性,因此该条带对应于抗M2的主要抗原性。用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)进行的滴定实验表明,该抗原制剂用于上样的最佳浓度为0.04 mg/ml。我们还进行了滴定实验以确定二抗和血清样本的最佳稀释度。结果表明,二抗抗IgG和抗IgM的最佳稀释度分别为1:3000和1:1000。血清样本的最佳稀释度为1:10(2)。此外,如果检测未稀释的血清或使用抗IgG或抗IgM作为二抗,蛋白质印迹技术即使对于传统方法检测为阴性的AMA阴性PBC患者的血清也能给出阳性结果。因此,蛋白质印迹技术比传统分析方法更灵敏。基于这些结果,我们将能够以最高效率检测抗M2,从而提高我们研究抗M2与PBC病理状况之间关系的能力。